|
|
The TAS is a solid state, microprocessor controlled system for monitoring coagulation and fibrinolysis using a small drop of whole blood, plasma or quality control material. Weighing just over 4 pounds, the analyzer is flexible enough for use in a variety of testing environments including the clinical laboratory, OR, Cath Lab, ICU, CCU, dialysis, and outpatient clinics.
TAS analyzer features include:
- 1000 result internal memory
- AC / DC power operation
- Alpha-numeric key pad
- Patient identification
- Operator access / identification
- Quality control warning / lockout
- RS232 serial port
- Normal and Quality Control Range Check
|
|
|
|
|
|
The TAS stores each test result with date and time, patient identification, operator identification, test name and lot number automatically. Precise pipetting of reagents or samples and manual timing skills are not required with the TAS test cards. The QC lockout feature insures that quality control has been performed and meets specific performance criteria before patient samples can be processed. The RS232 serial port allows for printer or PC interface.
TRAQS is a software program for management of test results stored in memory in the TAS. TRAQS allows test results from the TAS to be sorted by date, operator, patient, test type, and analyzer serial number. TRAQS will also “flag” patient test results that are outside of user defined ranges.
CVDI offers a variety of PT tests to meet a wide range of testing needs including:
- PT (ISI
 1.6)
- PT-ONE (ISI 1.0)
- PT-NC (ISI 1.0) - for “finger stick” or non-citrated samples
- Dade PT (ISI 2.0)
The TAS aPTT test card is to be used with the TAS analyzer and is intended for the determination of the activated Partial Thromboplastin Time of citrated whole blood or plasma.
The TAS HMT is an alternative to the Activated Clotting Time (ACT). The HMT card together with the TAS analyzer is intended for rapid monitoring of the effects of moderate to high heparin levels (1 to 10 U/mL) on coagulation. The HMT, unlike the ACT, uses a much smaller sample (35µl vs. 2.0mL), utilizes either citrated or non-citrated whole blood and is unaffected by hypothermia and hemodilution. Studies by independent trial examiners also indicate that the HMT is less affected by Aprotinin than the ACT.
PharmaNetics offers liquid, bi-level Quality Controls for each of its tests. These are simple, single use controls which eliminate the measurement of diluent and lengthy equilibration time. Each control vial contains lyophilized material in a glass ampoule suspended in pre-measured diluent. To use the PharmaNetics' TAS Quality Controls the operator simply crushes the ampoule containing the lyophilized material and shakes the vial for 30 seconds. The control is then ready to use immediately.
|
|
